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 Research using in vitro cell cultures are frequently conducted under static growth 
conditions. Cells growing in vivo, however, grow in a highly dynamic and interactive environment, 
where they receive cues in the form of mechanical stimuli from their surroundings. Lung cells, for 
example, are continually exposed in vivo to a cyclic tensile stretch during normal inhalation and 
exhalation. The absence of a mechanically representative environment could have important 
implications for research and development, particularly in the context of drug discovery. We 
hypothesize that tensile (mechanical) forces applied to two non-small cell lung cancer cell lines, 
bronchoalveolar H358 cells and alveolar A549 cells, play an important role in determining cellular 
response to chemotherapeutic agents. In order to investigate changes resulting from exposure to 
tensile stretch, we first looked at changes in proliferation and expression of a few cellular markers 
associated with epithelial-mesenchymal transition (EMT). Next, we looked at changes in cell cycle 
distribution and expression of a few cell-cycle checkpoint proteins. Finally, we studied the effect 
of a tensile force on the efficacy of three chemotherapeutic agents. We found that a tensile force 
significantly reduces cellular proliferation and causes significant shifts in cell cycle distribution. 
Mechanically active culture environments led to decreased efficacy of cisplatin and increased 
efficacy of Zactima. These results indicate that a mechanically active culture environment does 
impact cell survival and protein expression, and has important implications in the context of the 
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Chapter 1: Introduction 
 
1.1 Background and Rationale 
Lung cancer is expected to account for approximately 14 % of new cancer cases and over 
one quarter of cancer deaths in 2016, making it the leading cause of cancer death in both men 
and women [1]. Of those lung cancer cases, approximately 85 % will be non-small cell lung cancer 
(NSCLC), indicating a continued strong need for therapies that are capable of effectively targeting 
the diverse types of NSCLC [2]. During the discovery for a new drug candidate, in vitro and in vivo 
experiments are conducted to establish the drug candidate’s activity, efficacy and safety before 
proceeding to clinical trials. Animal models have long been beneficial and integral components of 
pre-clinical drug studies for the development of new drugs of all types, however, 85 % of novel 
drugs do not survive the transition from pre-clinical in vivo animal model to human clinical trials 
[3]. Aside from ethical concerns involved, the use of animal models is very costly financially but 
carries poor predictive power for which drugs will successfully make the translation from pre-
clinical animal model to human clinical trial, due at least in part to substantial differences in cellular 
pathways and gene expression patterns that exist between species. There is a need for testing 
approaches that are able to more reliably predict efficacy and safety of new drug candidates in 
humans [4, 5], and the development of in vitro systems that serve as better organ-level mimics of 
in vivo human cellular conditions could potentially be an attractive supplement, if not eventual 
alternative, to existing drug discovery models. 
Traditional in vitro studies have involved culturing cellular monocultures in plastic tissue 
culture plates. While this approach has served a beneficial purpose, it fails to capture the complex 
environment cells experience in the body, where cells exist in a dynamic three-dimensional world 
interacting with other cell types, non-cellular materials, and a variety of mechanical stimuli. New 
developments are pushing pre-clinical experimental model development toward cellular co-
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cultures, more complex tissue cultures, and more complex three-dimensional environments [6], 
however, the development of representative models that capture the complexity of an in vivo 
environment in an in vitro context is still in its infancy. The integration of mechanical stimulation 
with cell culture is an important step in further bridging the gap between the dynamic in vivo 
environment and traditionally static in vitro culture models. 
1.2 Mechanotransduction 
The body is a dynamic cellular environment, with cells continuously being exposed to a 
variety of mechanical signals. The respiratory system, specifically the lung, is one marked 
example of the dynamic nature of the body, with lung cells continually experiencing various types 
of mechanical forces with each inhalation and exhalation. The airway, including the bronchus, 
bronchioles and the alveoli, experience shear forces as air flows into the lungs, and epithelial cells 
experience both tensile and compressive forces during each inhalation and exhalation. Very 
briefly, the epithelial cells that comprise the airway attach to the extra-cellular matrix, a complex 
network of locally-secreted proteoglycans, collagens and matrix proteins, such as laminin and 
fibronectin, through cell adhesion receptors on the cellular surface that span the cellular plasma 
membrane. These cell adhesion receptors connect via intermediary proteins to the interior of the 
cell to various microfilaments of the cytoskeleton, such as actin filaments and intermediate 
filaments. This coupling of the extracellular matrix to intracellular cytoskeletal elements allows for 
the transmission of external physical cues to the interior of the cell, ultimately affecting cellular 
changes at the nuclear level that effect all aspects of a cell’s life, from gene expression to cellular 
positioning and motility, to cell division [7]. A generalized schematic of cellular 
mechanotransduction is depicted in Figure 1. 
Much of our understanding of mechanotransduction began with animal studies, and many in 
vivo animal studies of the lung have focused on studies of fetal development. Fetal breathing 
movements are important for the normal development of lung, and our current understanding of 
11 
the importance of fetal breathing movements is heavily dependent on previous work done in 
animal models. A variety of in vivo approaches have been taken toward understanding lung 
development, and each of these has led to a deeper understanding of the importance of 
mechanical forces in the developing lung. 
The lungs are filled with fluid during development, and small changes in the fluid volume and 
pressure allow for a controlled lung expansion and contraction that is important for formation of a 
healthy lung. Early studies of fetal sheep showed the importance of in utero lung fluid flow that 
accompanies fetal breathing movements through controlled expansion and contraction of 
developing lung tissue on healthy lung growth [8-11], and the cessation of breathing movements 
through a variety of means results in hampered lung development [12-16]. These studies helped 
to show us that a mechanically active environment was necessary for normal lung development 
and laid the groundwork for a basic understanding of lung mechanotransduction, but were limited 
in their ability to elucidate cellular activity associated with mechanical stimulation. Deconvolution 
of the mechanisms behind the treatment and the observed effect can be challenging on larger 
whole-organism level studies. Understanding mechanotransduction at cellular-level necessitate 
the precision and more tightly controlled conditions of in vitro models, and these factors contribute 
to the decreased popularity of animal models in mechanotransduction studies. Although no in 
vitro models perfectly mimic in vivo mechanical forces, bioreactors can be used to simulate 
breathing and study their cellular effects in vitro. 
1.3 Bioreactors as In Vitro Models 
Bioreactors are often used to simulate various types of in vivo forces such as tensile, 
compressive, and shear forces and perform in vitro studies to understand the effects of applied 
forces on cellular behavior. In order to mimic the motion of the lung during respiration, lung cells 
are often subjected to cyclic tensile forces. With this approach cells are typically cultured on a 
flexible elastomeric membrane, such as polydimethylsiloxane (PDMS), covalently coated with a 
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basement membrane component. A cyclic tensile force is then applied in one or more directions, 
allowing for physical manipulation of the cellular substratum in order to simulate the desired 
mechanical effect, which cells experience through interaction with the substratum as well as with 
neighboring cells. 
Selection of the appropriate mechanical force profile is important when attempting to mimic 
the dynamic nature of the in vivo conditions in an in vitro model. Although the precise change in 
surface area experienced by cells in the lung in vivo remains unclear, cellular injury in vitro has 
been shown to occur when changes in cell surface area exceed 37 % [17, 18], a magnitude 
corresponding to inhalation greater than total lung capacity. The frequency of changes to cellular 
surface area in cyclic stretch profiles leads to cell damage primarily within the first few minutes of 
exposure to stretch, and cell damage increases with increased amplitude and magnitude [18]. 
Changes in cellular surface area up to 30 %, however, do not injure cultured cells [18, 19]. 
Applying a uniaxial stretch is one widely used approximation to study the effect of mechanical 
forces on lung cells. In this approach, cells are cultured on elastomeric strips or chambers and 
stretched from one or both ends, delivering a homogeneous tensile force to the cells along a 
single axis. Uniaxial stretch has been applied to cells grown on fibronectin-coated silicon 
chambers [19], strips of intact lung tissue [20], or in bending dishes that are physically stretched 
from above over loading supports [21]. The uniaxial stretching of cells and tissues has provided 
much insight into lung biomechanics and biochemical behavior, however, it does not necessarily 
provide a representative model of the forces experienced by lung tissue in vivo.  
The use of biaxial distension adds force in an additional direction in an attempt to better 
model in vivo mechanical forces in vitro. Vacuum pressure has been applied directly to plastic 
petri dishes to deliver a tensile or compressive force along two axes [22]. More modernly, a flexible 
membrane acts as a cellular substratum through which mechanical stimulation is delivered. 
Polydimethylsiloxane (PDMS) membranes are frequently used in such a context, and have been 
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used as a mounting surface for precision-cut tissue slices [23] or as a cell culture surface built 
into multi-well culture plates. The plates are used in conjunction with a bioreactor designed to 
distend the flexible bottoms of the plates, delivering both circumferential and radial strains to the 
cultured cells. The application of a biaxial force to cells has been accomplished through a convex 
deflection of the culture surface from below using air [24] or liquid [25, 26], through pushing the 
culture surface down over a post [27], or driving a piston upward to stretch the culture membranes 
[28]. One common methods employed involves the use of vacuum pressure to pull the culture 
membranes down over a fixed post. The Flexcell strain unit (Flexcell International), one 
commercially available instrument commonly used in mechanotransduction studies, uses this 
approach. With the Flexcell device, cells are cultured in plastic six-well plates that contain flexible 
membranes as the bottom culture surface. Vacuum pressure is utilized to pull the flexible 
membranes down over a Delrin post using a force profile and frequency customizable through a 
software interface. Flexcell units have been used rather extensively to study the effects of 
mechanical strain on lung cell differentiation [29-31], proliferation [32, 33], [34], and gene 
expression [35-37], to list a few examples. The ability to provide a biaxial stretch to cultured cells 
is an improvement over application only along a single axis, and its use for lung epithelial cell 
culture is the focus of this thesis.  
1.4 Description of Cell Culture 
For each of the studies described in this thesis, the FX-4000 Flexcell Tension Plus system 
by Flexcell International Corporation was used to apply a tensile strain to cultured cells. All cells 
were cultured in 35 mm diameter, 6-well BioFlex plates with flexible silicone elastomer well 
bottoms. Well bottoms were pre-coated with covalently bonded Collagen I to promote cellular 
adhesion. Cells were allowed to grow for 24 hours prior to the administration of tension to promote 
cellular adhesion to the well surface. 
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After 24 hours, plates in the mechanically active culture groups were loaded on Equibiaxial 
loading stations, designed to apply a uniform radial and circumferential strain to cells. Each six-
well culture plate fits in a gasket in one of four positions available on the loading station base. 
Each well of the plate fits over a Delrin planar-faced cylindrical loading post 25 mm in diameter; 
when vacuum is applied to the loading station base the well bottoms deform across the loading 
post face, creating equibiaxial strain (see Figure 2 for the base station assembly). A thin layer of 
Loctite silicone lubricant is applied to the top and sides of each loading post prior to assembling 
culture plates in the loading station. A plexiglass cover is applied to the top of assembled loading 
stations, and a 5 to 10-pound weight is applied to the top of the plexiglass cover to ensure culture 
plates remain firmly seated in the base station. The entire base station assembly is housed in a 
cell culture incubator at 37 °C, a 5 % CO2 concentration and 95 % relative humidity. 
Vacuum pressure is applied using a Leybold Trivac B vacuum pump controlled by a software 
interface. Cells exposed to forces were subjected to a half-sinusoidal cyclic strain profile of 20% 
maximum membrane elongation at 0.5 Hz frequency per step (2 second elongation followed by 2 
seconds relaxation, or 15 cycles per minute with an average strain of 10% per cycle). Cells 
cultured under static conditions in these experiments were cultured in the flexible-bottom six-well 
culture plates described for the mechanically active culture groups, but were not connected to 
vacuum pressure. See Figure 2 for a basic overview of the cell culture and tension delivery 
mechanism used for these studies. 
1.5 Project Scope 
This thesis examines the effect of simulated in vivo mechanical stimulation on in vitro cultured 
cells with an eye toward its utilization in a drug-discovery context. Two non-small cell lung cancer 
cell lines in particular were investigated: H358, a bronchoalveolar cell line, and A549, a pulmonary 
epithelial cell line. Chapters 2 and 3 report findings related to a few general biological changes 
that occur with mechanically stimulated cells in vitro with respect to proliferation. Chapter 2 looks 
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at proliferative and morphological changes occurring with exposure to mechanical stimulation, 
then at changes in cellular levels of a few proteins associated with cellular epithelial-to-
mesenchymal transition. Chapter 3 targets cell cycle changes that occur with stimulation; changes 
in the number of cells present in each stage of the cell cycle are examined and proteomic changes 
in a few key cell cycle proteins are investigated. Chapter 4 discusses in vitro drug studies 
conducted in a mechanically active culture environment with a few different chemotherapeutic 
agents, with particular attention to proliferative changes observed. Chapter 5 then provides 
general conclusions and recommendations based on these findings. 
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Much in vitro research has been conducted using bioreactors to study the relationship 
between lung dynamics and cellular behavior, and many of these studies have focused on the 
fetal development of lungs. Fetal breathing movements expose the lungs to mechanical forces 
even before they serve the purpose in gas exchange, and play an important role in fetal lung 
development [38].  
Fibroblasts play an important role in extracellular matrix deposition and regulation of alveolar 
structure, and the role of mechanical stimulation in their proliferation is a subject of debate. Human 
lung IMR-90 fibroblasts showed an increase in proliferation when exposed to a cyclic biaxial 
stretch in two-dimensional cultures, and cellular replication is further increased in IMR-90 cells 
cultured in media extracted from the wells of mechanically stimulated cells [39]. In contrast, 
fibroblasts isolated from rats during the canalicular stage of development demonstrated a 
decrease in proliferation in response to a tensile force [40]. Liu et al. studied both two-dimensional 
cultures and “organotypic” cultures, three-dimensional co-cultures composed of mixed fibroblast 
and epithelial cells isolated from rats during the canalicular stage of lung development (at 19 days 
of gestation). While measurement of DNA incorporation of [3H] thymidine showed no significant 
change in proliferation in two-dimensional cultures, increases in proliferation in three-dimensional 
organotypic cultures in response to a cyclic uniaxial stretch were observed [41, 42]. The 
decreases in proliferation in two-dimensional fibroblast cultures [40] and the increases in three-
dimensional organotypic cultures [41, 43] could be attributed to differences in the applied stretch 
(uniaxial or biaxial) or differences in cell-cell contacts between two and three-dimensional cultures 
[43]. Xu et al. reported that strain-enhanced proliferation is gestation dependent, with proliferation 
being the highest during the early canalicular stage at 19 days of gestation; this gestational 
response to mechanical force appears to be regulated by cellular interactions with the 
17 
mesenchyme [44]. These mostly undifferentiated and loose connective tissue cells of mesodermal 
origin easily migrate and may have different responses to drugs when compared to cells of 
epithelial origin. Epithelial-mesenchymal transitions and vice versa (mesenchymal-epithelial 
transitions) are critical in cancer pathology; hence the effect of forces could be important in 
research and development applications in oncology. 
2.2 Methods 
2.2.1 Cell Culture 
The bronchoalveolar line NCI-H358 (ATCC) and the alveolar adenocarcinoma line A549 
(ATCC) were obtained from American Type Culture Collection (ATCC). H358 cells were cultured 
in RPMI-1640 (Sigma Aldrich) and A549 cells were cultured in HAM’s F12K (ATCC). Both were 
supplemented with 10% Fetal Bovine Serum (Sigma Aldrich) and 1% Penicillin Streptomycin 
(Sigma Aldrich). Cells were passaged in 75 cm2 culture flasks at 37° C in 5% CO2, and trypsinized 
using TrypLE Express containing phenol red (Gibco). Both cell lines were individually cultured in 
six-well Bioflex Collagen I plates (Flexcell International). H358 cells were seeded at 100,000 
cells/well and A549 at 20,000 cells/well for both static wells and wells exposed to forces as 
described in Chapter 1.4. 
2.2.2 Application of Mechanical Stimulation 
Cells were allowed to attach to the plate for 24 hours prior to the application of forces. After 
24 hours, a FX-4000 Tension plus unit (Flexcell International) was used to apply a tensile force 
to cells. Cells exposed to forces were subjected to a cyclic strain of 20 % maximum strain for 2 
seconds, followed by 2 seconds of rest (15 cycles per minute with an average strain of 10 % per 
cycle). The total duration of the experiment was 144 hours. 
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2.2.3 Cell Harvesting and Counting 
Cells were harvested from each well individually at two time points, 72 hours and 144 hours, 
using TrypLE (Gibco) and transferred to new labeled six-well plates in order to maintain treatment 
group identities. Briefly, media was removed from the culture wells to their corresponding new 
labeled six-well plates and 300 µL of TrypLE was added to each culture well. Each well’s reserved 
media was then used to transfer dislodged cells from the culture wells to the new plates. The 
volume of each well was measured and brought up to a total volume of 4 mL using phosphate-
buffered saline. Cell counts were then taken using 1 mL of cells/media from each well using a Vi-
CELL Cell Counter (Beckman Coulter). The viable cell count was then converted to a cell count 
per original 4 mL well by multiplying each cell count by four. Results shown are mean viable cell 
counts plus or minus the standard deviation. Differences in viable cells counts between static cell 
cultures and dynamic cultures at each time point were statistically analyzed with GraphPad Prism 
Version 5.04 (GraphPad Software, Inc.) using a two-tailed Student’s t-test with Welch’s correction. 
Significance was set at p < 0.05. The experiment was repeated on three separate days. 
2.2.4 Morphological Examination 
Sample wells for both cell lines were visually examined at two time points: at 72 hours and at 
144 hours. Visual examination was conducted using an Olympus IX71 inverted microscope with 
10x objective lens, and representative pictures taken for each cell line and each forces group at 
both time points. 
2.2.5 Western Blotting of Select EMT Markers 
Whole cell lysates were created for both cell lines at both 72 hours and 144 hours, and 
western blotting was conducted for selected protein markers associated with either an epithelial 
phenotype or a mesenchymal phenotype. Cells were harvested using TrypLE Express followed 
by centrifugation at 200 x g at 4 °C. Cell pellets were resuspended and washed three times with 
cold PBS (Gibco). Cells were then resuspended in RIPA buffer (Sigma Aldrich) and lysed using 
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three freeze/thaw cycles alternating between liquid nitrogen and a 37 °C water bath. Protein 
concentrations were determined using a Detergent Compatible (DC) Protein Assay (Bio-Rad). A 
total of 30 µg of each protein sample was mixed with E-PAGE loading reagent (Invitrogen) and 
NuPAGE reducing reagent (Invitrogen). Samples were heated at 95 °C for 5 minutes and loaded 
in wells of 8% E-PAGE gels (Invitrogen). The separated proteins were then transferred to 
nitrocellulose using iBlot transfer stacks (Invitrogen). Blots were blocked in 0.1 % Tween in Tris-
buffered saline with either 5% bovine serum albumin or 5 % milk for 1 hour at room temperature. 
Blots were then incubated with antibodies to E-cadherin, β-catenin, γ-catenin, Vimentin, N-
cadherin, or Fibronectin at 1:500-1:1000 (all Santa Cruz Biotechnology, Inc.) at 4 °C overnight. 
Beta-actin was used as a loading control at 1:3000 (Abcam). All blots were washed and incubated 
with a corresponding secondary IgG-HRP linked antibody, either goat anti-rabbit (Santa Cruz 
Biotechnology, Inc.) or goat anti-mouse (Santa Cruz Biotechnology, Inc.) for two hours at room 
temperature, then incubated with Immobiolon Western Chemiluminescent HRP substrate 
(Millipore) according to manufacturer’s instructions. Images were obtained using an AutoChemi 
System (UVP BioImaging Systems). 
2.3 Results 
2.3.1 H358 Bronchoalveolar Epithelial Cells Fail to Proliferate with Mechanical Stimulation 
At 24 hours, just prior to the application of forces to the “With Forces” group, viable cell counts 
for the statically cultured cells and cells cultured with tensile stretch show no significant 
differences. Shortly after the application of forces to the “With Forces” group, however, the viable 
cell count numbers stagnate. The “Without Forces” group viable cell count numbers show a 
roughly exponential growth pattern, whereas the group exposed to tensile stretch did not. 
Significant differences in viable cell counts between statically cultured cells and cells grown under 
stretched conditions appeared at 48 hours, and continued at throughout the duration of the 
experiment through the 144-hour time point (Figure 3). 
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2.3.2 H358 Bronchoalveolar Epithelial Cells Detach and Form Aggregates with Mechanical 
Stimulation 
 
Morphological examination of representative wells for both the “With Forces” and “Without 
Forces” group at 72 hours. The “With Forces” group showed detachment of H358 cells from the 
plate membrane surface and formation of cellular clusters, or spheroidal type aggregations. These 
cellular aggregations were still present at the 144-hour time point (Figure 4). 
2.3.3 A549 Alveolar Epithelial Cells Fail to Proliferate with Mechanical Stimulation 
At 24 hours, similar to proliferation results for H358 cells above, viable cell counts differ only 
slightly between cells cultured in static plates and cells cultured with a cyclic tensile force. 
However, again similar to the H358 cell proliferation results, viable cell count numbers fail to 
increase in the “With Forces” group. The “Without Forces” group again shows viable cell count 
numbers that increase roughly exponentially, leading to significant changes in cell counts between 
cells cultured with tensile stretch and without tensile stretch at 72 hours and continuing through 
144 hours (Figure 5). 
2.3.4 A549 Alveolar Epithelial Cells Remain Adherent with Mechanical Stimulation 
Morphological examination of representative wells for both the “With Forces” and “Without 
Forces” group at 72 hours. Both the “With Forces” and “Without Forces” groups remained 
adherent through both time points (Figure 6). 
2.3.5 Increased Epithelial Marker E-cadherin and Decreased Mesenchymal Markers with 
Mechanical Stimulation of Bronchoalveolar Epithelial Cells 
 
For H358 cells exposed to stretch, a modest increase in the epithelial marker E-cadherin was 
observed at both 72 hours and 144 hours (Figure 7a). Mesenchymal markers vimentin and 
fibronectin showed decreased levels with exposure to stretch, with vimentin levels decreased at 
72 hours with forces, and fibronectin levels decreased at 144 hours with forces (Figure 8a). 
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2.3.6 Decreased Epithelial Marker β-catenin and Increased Mesenchymal Markers 
Vimentin and N-cadherin with Mechanical Stimulation of Alveolar Epithelial Cells 
 
For A549 cells, β-catenin was decreased in stretched cells at 144 hours, though expression 
was low for both stretched and unstretched cells at 144 hours compared to that at 72 hours (Figure 
7b). Vimentin appeared increased in stretched cells at 144 hours and N-cadherin increased in 
stretched cells at both time points (Figure 8b). 
2.4 Discussion 
An approximately exponential growth profile was observed in both cell lines without the 
presence of a cyclic stretch. Each cell line has a very different growth rate; seeding densities were 
adjusted to yield approximately equivalent cell counts in both lines in non-stretched cells at the 
end of the experiment. In the presence of cyclic stretch, both cell lines showed a “stagnation” of 
proliferation. Cells exposed to stretch failed to proliferate. The morphological changes observed 
with these two cell lines were interesting, as they were different for each line. The H358 cell line 
formed three-dimensional aggregates that were detached from the surface of the plate. This 
behavior was observed at both time points in the experiment. It is possible that the cells exposed 
to stretch were dying and detaching from the plate, but dead and detached cells would not 
necessarily be expected to form and maintain spheroidal aggregates. Cells, alternately, may have 
been detaching from the plate while still alive. The exposure to stretch could have altering 
expression of cell surface proteins that play a role in cell-cell interactions and cellular adhesion to 
the plate membranes. This was not observed in the A549 cell line, which stayed adherent to the 
plate at all time points and under all mechanical culture conditions. The changes in protein 
expression may lend some clues to the changes in morphology observed in H358 cells with 
stretched culture conditions. Cells secrete fibronectin into the extracellular matrix where it binds 
ECM components such as collagen. Decreased levels of fibronectin at 144 hours in the H358 cell 
line would mean less binding to collagen, which could help explain the detachment observed. 
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H358 cells also showed increased E-cadherin levels, a molecule heavily involved in cell-cell 
interactions, at both time points. This again fits with the observed aggregation of these cells, which 
would involve increased cell-cell contact. Whether the detachment preceded the changes in 
fibronectin and E-cadherin expression or vice versa, however, remains unknown.  
Little change in protein expression of E-cadherin, β-catenin, or γ-catenin was observed 
between active and static cultures in A549 cells, though mechanically active cultures of A549 did 
show increases in N-cadherin levels at both time points, and increases in vimentin levels at 144 
hours. Increased N-cadherin and increased vimentin levels are associated with epithelial-
mesenchymal transition (EMT), a critical process by which malignant tumors become more 
invasive and develop metastases. Decreases in epithelial markers such as E-cadherin, β-catenin, 
and γ-catenin and increased levels of mesenchymal markers including vimentin, N-cadherin, and 
fibronectin are all signs in a cellular shift from an epithelial to mesenchymal phenotype. Increased 
E-cadherin at all time points coupled with decreased Vimentin levels at 72 hours and decreased 
fibronectin at 144 hours in the already more-epithelial like H358 cell line in mechanically active 
cell culture hint toward this cell line acting even more epithelial-like, and so showing less signs of 
EMT, with simulated in vivo forces. Similarly, the more mesenchymal A549 cell line displayed 
EMT marker levels consistent with a more mesenchymal phenotype in mechanically stimulated 
cells through increased vimentin at 72 hours and increased N-cadherin at all time points.  
One potentially important limitation of this study concerns the dissociation of cells from the 
plate culture membranes. Since some fraction of H358 cells are detaching from the plate, the 
detached cells are not experiencing the desired tensile strain. The strain applied to cells in this 
experiment was, at 20 %, relatively high. This high level of strain may itself potentially impact 
cellular adhesion to the plate membranes as well as cellular response to an applied strain. 
Decreasing the strain applied to cells may help to mitigate the observed detachment of H358 cells 
from their culture surfaces. A study of the application of varying stretch profiles could be used 
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toward this end. The application of varying stretch profiles could additionally provide information 
regarding changes in cellular response with changing amounts of stretch. The detached clusters 
of cells floating in the media may likely instead be experiencing some fluid flow stimulation due to 
any movement of the media that accompanies the cyclic distension of each well. The effects of 
this type of stimulation were not within the scope of this project, but could be interesting to 
investigate in its own right. Questions as to how stimulation of cells leads to detachment, whether 
through physical damage to cell-matrix interactions, through changes in expression of ECM-
interacting proteins as observed above, activation of the secretion of matrix metalloproteinases 
or other extracellular matrix degrading enzymes [45], or through some other means still remain to 
be answered. 
Relating to the previously mentioned limitation of cellular detachment, the method used to 
determine cell viability for this study is itself another potential limitation. Trypan blue exclusion 
was utilized to determine viable cell counts, but as this method stains intact cells, it cannot be 
used to distinguish between cells that are healthy and cells that are alive but losing the ability to 
function normally. An assay utilizing cellular metabolic capability for determining cellular viability, 
such as CellTiter-Blue, for example, would be able to distinguish between healthy cells and intact 
cells with diminishing functionality, making this a good inclusion for the proliferation study 
conducted here. 
In conclusion, a marked change in proliferation was observed with exposure to a cyclic tensile 
stretch, and this was coupled with shifts in EMT marker expression in both cell lines. Though the 
shifts in EMT marker expression may help explain some of the cellular detachment observed in 
stretched cells, these shifts do not readily speak to the proliferative stalling we observed in both 
cell lines. This led us to question how cell cycle progression is impacted by exposure of cultured 
cells to a mechanical stretch; a study of cell cycle progression is the focus of Chapter 3. 
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Chapter 3: Changes in Cell-Cycle Progression in Mechanically Active Cell Cultures 
 
3.1 Introduction 
Normal cellular proliferation involves the proper coordination and control of events during cell 
cycle progress, with the loss of cell cycle control leading to conditions such as cancer. Mechanical 
forces have been shown to affect the proliferation of cells by altering the progression of events at 
differing stages in the cell cycle [40, 46-49]. Increases in proliferation have been seen human lung 
fibroblasts [50], airway smoot muscle cells [32, 51], and lung epithelial cells [33, 34, 39, 41] with 
exposure to a cyclic stretch. In cultured vascular smooth muscle cells, a cyclic strain causes a 
G1/S cell cycle arrest [46]. Sedding et al., however, used cyclic strain to instead promote entry of 
quiescent vascular smooth muscle cells into the cell cycle [47]. A G2/M accumulation has been 
observed in cardiac fibroblasts exposed to cyclic strain [48], and fetal rat lung fibroblasts show 
decreased proliferation and increased apoptosis [40]. Fetal rat lung epithelial cells exhibit 
increased CDK inhibitor protein expression and nuclear localization in response to stretch, 
resulting in a G1 cell cycle arrest in vivo [49]. A variety of responses to mechanical stimulation 
have been observed; the results are far from clear-cut. Despite advances in knowledge regarding 
how mechanical stimulation affects cell cycle progression in a variety of cell types, the effect of 
mechanical stimulation on cell cycle progression in cancer cells, cells notable for possessing 
altered cell cycle controls, remains largely unexamined. 
The role of changes in cell cycle controls and apoptosis have been investigated as 
mechanisms behind the observed changes in proliferation in response to mechanical forces [40, 
46, 52]. Cells progress through well-defined stages during the cell cycle prior to mitosis. The 
orderly duplication of non-chromosomal cellular contents in the G1 phase, followed by the 
duplication of chromosomes in the S phase, is necessary for mitosis and the proliferation of cells. 
Inhibition of a G1/S phase transition has been observed in vascular smooth muscle cells in 
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response to cyclic stretch [46]. In a similar study, Sanchez-Esteban et al. observed significant 
increases in quiescent (G0) and G1 phase cells and significant decreases in S phase cells in 
biaxially stretched fibroblasts, indicating an inhibition of cell cycle progression [40]. The enhanced 
apoptosis observed is due to increased caspase-3 activation under stretched conditions [40, 52]. 
This evidence suggests that stretch may serve as a mechanism for controlling proliferation and 
guiding normal lung development by inducing increases in apoptosis and changes in cell cycle 
signaling events. 
The uncontrolled proliferation that occurs in cancer results for a loss of ability to regulate cell 
cycle progression [53, 54]. In fact, cancer can be viewed as a disease of the cell cycle. A large 
number of therapies designed to target cancer that are currently in use are mitotic inhibitor that 
target actively proliferating cells. The effectiveness of anti-cancer therapies that target actively 
proliferating cells, then, may be altered by changes in cell cycle progression that result from 
exposure to a repeated mechanical stimulus. During the drug discovery process, many potential 
anti-cancer agents are promising against cells grown under static conditions, but fail as they are 
moved to animal models that serve as a more physiologically representative environment. 
Ailments such as lung cancer involve the aberrant growth of cells in a mechanically active 
environment, and so studies conducted on statically grown cells may not be capturing the whole 
clinically relevant picture. An understanding of mechanotransductive pathways and cellular 
responses to strain, particularly in the lung, may prove to be beneficial in the area of drug 
discovery. To this end, this cell cycle experiment was conducted to examine changes in cell cycle 
accumulation due to culture in a mechanically active environment. The distribution of cells in each 
phase of the cell cycle, G0/G1, S, G2, or M phase, was determined using flow cytometry. To 
further understand the changes in cell cycle distribution observed, western blotting was used to 
determine changes in the relative expression of three cell cycle related proteins important for M-
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phase progression: Cyclin B1, CDK1, and p21 (see Figure 9 for a generalized depiction of the cell 
cycle and checkpoint proteins in this study). 
3.2 Methods 
3.2.1 Cell Culture 
Two non-small cell lung cancer (NSCLC) lines, a bronchoalveolar line NCI-H358 (ATCC), an 
alveolar adenocarcinoma line A549 (ATCC), and a non-tumorigenic lung cell line, NL-20 (ATCC), 
were obtained from American Type Culture Collection (ATCC). H358 cells were cultured in RPMI-
1640 (Sigma Aldrich) and A549 cells were cultured in HAM’s F12K (ATCC). Both were 
supplemented with 10% Fetal Bovine Serum (Sigma Aldrich) and 1 % Penicillin Streptomycin 
(Sigma Aldrich). NL-20 cells were cultured in HAM’s F12K media supplemented with 2.7 g/L 
glucose (Sigma Aldrich), 0.1 mM nonessential amino acids (Sigma Aldrich), 0.005 mg/ml insulin 
(Sigma Aldrich), 10 ng/ml epidermal growth factor (Sigma Aldrich), 0.001 mg/ml transferrin (Sigma 
Aldrich), 500 ng/ml hydrocortisone (Sigma Aldrich), and 4% Fetal Bovine Serum (Sigma Aldrich). 
Cells were passaged in 75 cm2 culture flasks at 37 °C in 5 % CO2, and trypsinized using TrypLE 
Express containing phenol red (Gibco). 
All three cell lines were individually cultured in six-well Bioflex Collagen I plates (Flexcell 
International). A differential seeding density was again used for each cell line to achieve an 
approximately equivalent degree of confluence after three days as described in Chapter 1.4. NL-
20 cells showed growth rates comparable to H358 cells, so the seeding density used for H358 
was adopted for NL-20 in this study. Both H358 and NL-20 cells were seeded at 100,000 cells/well 
for static cells and 170,000 cells/well for the group exposed to forces. A549 cells were seeded at 
20,000 cells/well for static cells and 35,000 cells/well for cells exposed to forces. 
3.2.2 Application of Mechanical Stimulation 
Cells were allowed to attach to the plate for 24 hours prior to the application of forces. After 
24 hours, a FX-4000 Tension plus unit (Flexcell International) was used to apply a tensile force 
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to cells, as described in Chapter 1.4. The duration of exposure to forces was either 48 hours for 
the 72-hour group, or 120 hours for the 144-hour group. 
3.2.3 Cell Cycle Analysis 
In order to examine the effect of an applied mechanical strain on cellular proliferation, we 
looked at the effect on cell cycle progression. Flow cytometry was used to determine the number 
of cells in G0/G1, S, G2, and M phases. Asynchronous cells were harvested from plates using 
TrypLE (Gibco). Cells were pelleted at 1000 rpm and washed with phosphate buffered saline 
(PBS) three times, then fixed in cold 90% ethanol in PBS overnight. Fixed cells were then 
centrifuged and resuspended in staining buffer supplemented with fetal bovine serum (BD 
Biosciences). To determine the number of cells in M-phase, cells were stained with rat anti-
histone H3 pS28 conjugated to BD Horizon V450 (BD Biosciences), then treated with a solution 
of propidium iodide containing RNase (BD Biosciences), as described previously [55]. The 
percentages of cells in each phase of the cell cycle were then determined with a BD LSR II flow 
cytometer (BD Biosciences) using BD FACSDiva software (BD Biosciences). Each analysis was 
conducted on separate days a minimum of three times. Flow cytometry data graphs were created 
and statistical analysis conducted with GraphPad Prism Version 5.04 (GraphPad Software, Inc.) 
using a Student’s two-tailed unpaired t-test with significance set at p < 0.05. Each experiment was 
repeated a minimum of three times. 
3.2.4 Western Blotting 
In order to follow up on cell cycle progression changes observed in the cell cycle analysis 
conducted using flow cytometry, particularly the changes in percentages of cells in M-phase, 
western blot analyses on whole cell lysates were conducted for p21, CDK1, and cyclin B1 
expression. Because significant changes in cell cycle progression were not observed in the non-
tumorigenic NL-20 cell line, only NCI-H358 and A549 cells were examined using western blotting. 
Cells were harvested using TrypLE Express followed by centrifugation at 200 x g at 4 °C. Cell 
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pellets were re-suspended and washed three times with cold PBS (Gibco). Cells were then re-
suspended in RIPA buffer (Sigma Aldrich) and lysed using three freeze/thaw cycles alternating 
between liquid nitrogen and a 37 °C water bath. Protein concentrations were determined using a 
Detergent Compatible (DC) Protein Assay (Bio-Rad Laboratories). A total of 30 µg of each protein 
sample was mixed with E-PAGE loading reagent (Invitrogen) and NuPAGE reducing reagent 
(Invitrogen). Samples were heated at 95 °C for 5 minutes and loaded in wells of 8% E-PAGE gels 
(Invitrogen). The separated proteins were then transferred to nitrocellulose using iBlot transfer 
stacks (Invitrogen). Blots were blocked in 0.1 % Tween in tris-buffered saline with either 5% 
bovine serum albumin or 5 % milk for 1 hour at room temperature. Blots were then incubated with 
antibodies to non-phosphorylated p21 at 1:200 (Santa Cruz Biotechnology, Inc.) non-
phosphorylated CDK1 at 1:100 (Millipore) or non-phosphorylated Cyclin B1 at 1:200 (Santa Cruz 
Biotechnology, Inc.) at 4 °C overnight. Beta-actin was used as a loading control at 1:3000 
(Abcam). All blots were washed and incubated with a corresponding secondary IgG-HRP linked 
antibody, either goat anti-rabbit (Santa Cruz Biotechnology, Inc.) or goat anti-mouse (Santa Cruz 
Biotechnology, Inc.) for two hours at room temperature, then incubated with Immobilon Western 
Chemiluminescent HRP substrate (Millipore) according to manufacturer’s instructions. Images 
were obtained using an AutoChemi System (UVP BioImaging Systems). 
3.3 Results 
3.3.1 H358 Cells Showed Increased G0/G1 and Decreased G2 Phase H358 Cells After 72 
Hours, But Decreased S-Phase and Increased M Phase at 144 Hours 
 
At the 72-hour time point, H358 cells exposed to forces showed a greater percentage of cells 
in G0/G1 than cells cultured statically, but showed fewer cells in G2 phase as compared to 
statically cultured cells (Figure 10a). This corresponded with increases in non-phosphorylated 
CDK1, cyclin B1, and p21 with a tensile stretch (Figure 10b). After 144 hours, a significant 
decrease in the percentage of cells in S phase was seen in stretched cells relative to unstretched 
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cells. The percentage of cells in M-phase in stretched cells was significantly increased relative to 
unstretched cells (Figure 10c). At 144 hours, levels of CDK1 and cyclin B1 in H358 cells exposed 
to a cyclic tensile force were relatively constant in comparison to non-stretched cells, while levels 
of p21 were increased (Figure 10d). Flow cytometry results for all are summarized in Table 1. 
3.3.2 A549 Cells Showed Increase Mitotic-Phase Cells after 72 Hours, but Decreased 
G0/G1 and S-Phase Cells after 144 Hours 
 
In A549 cells, there was a significant increase in M phase cells in cells grown with a tensile 
stretch relative to unstretched cells after 72 hours of forces (Figure 11a), corresponding with 
increases in cyclin B1, CDK1 and p21 at the 72-hour mark in mechanically active cell cultures 
(Figure 11b). Cells cultured with stretch showed a significant decrease in the percentages of cells 
in G0/G1 relative to statically cultured cells. S-phase distribution of cells was also decreased in 
stretched cells versus unstretched cells after 144 hours (Figure 11c). At 144 hours, decreased 
relative amounts of p21, cyclin B1, and CDK1 were seen (Figure 11d). Flow cytometry results for 
all are summarized in Table 1. 
3.3.3 NL-20 (Non-Tumorigenic) Cells Showed No Significant Changes In Cell Cycle 
Distribution 
 
NL-20 cells exposed to a cyclic distension did not show significant changes in the percentage 
of cells in any phase at either the 72-hour (Figure 12a) or the 144-hour (Figure 12b) time points. 
Flow cytometry results for all are summarized in Table 1. 
3.4 Discussion 
The purpose of this study was to investigate the effect of an applied cyclic tensile force on 
the distribution of cells in M-phase in one non-tumorigenic lung epithelial cell line and two non-
small cell lung cancer lines. Normal progression of the cell through the various phases of the cell 
cycle requires a carefully timed orchestration of events between numerous proteins that work to 
either promote or inhibit cell division at different points in the cell cycle. Cyclins and cyclin-
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dependent kinases (CDKs) in particular work as partners to control cell cycle progression. 
Members of the cyclin B family and CDK1 (cdc2) in particular interact to promote the entry of cells 
into G2/M. Their activity remains important through mitosis for spindle assembly [56] and 
deactivation of the Cyclin B1-CDK1 complex is necessary for mitotic completion. The cyclin-
dependent kinase inhibitor p21 works as a counterbalance to cyclin-CDK activity, inhibiting the 
activity of cyclin-CDK complexes throughout the cell cycle. The improper regulation of cell cycle 
protein levels and activity can result in loss of cell cycle control, leading to the uncontrolled 
proliferation that defines cancer cells. 
Although no significant changes were seen in the non-tumorigenic lung epithelial line, both 
non-small cell lung cancer lines showed significant changes at differing time points. The link 
between the changes observed in protein expression and changes in cell cycle progression in 
these cancer lines are not immediately clear. A549 cells showed a significant accumulation of 
cells in M-phase at the 72-hour time point in stretched cells, but this M-phase difference between 
stretched and unstretched cells was eliminated at the 144-hour time point, indicating that the 
accumulation was temporary. The significant M-phase increase in H358 cells at the 144-hour time 
point was accompanied by an increase in p21. This could be consistent with the G2/M arrest seen 
previously in cardiac fibroblasts cultured under stretched conditions [48]. The results from Liao et 
al. supported p53 involvement in cardiac fibroblast G2/M arrest [48]. H358 cells, however, carry 
a homozygous p53 gene deletion [57, 58], indicating that another mechanism must control the 
increased expression of p21. One possible explanation is increased p21 leading to increases in 
cell cycle progression from G2 to M phase. Transient hyper-phosphorylated forms of p21 in the 
nucleus have been shown to increase cyclin B-CDK1 activity [59], which would drive cells through 
G2 into M-phase. However, our stretch-induced decline in proliferation indicates that cells are not 
merely entering M-phase with greater frequency, but are showing a proliferative decline. At the 
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very least, p21-induced activity of cyclin B1-CDK1 as describe above would not be the sole 
explanation to the cell-cycle changes observed here. 
Another interesting possibility is induction of p21 independent of p53 through nuclear factor-
κB (NF-κB) as suggested by Wuerzberger-Davis et al [60]. They found an increase in G2/M arrest 
through p21 induction in an NF-κB-related manner. Changes in NF-κB levels occur in response 
to integrin stimulation through MAPK activation, and increases in NF-κB have been observed in 
osteoblasts in response to cyclic tension [61]. Increased p21 mRNA expression mirroring the 
protein expression changes seen in H358 cells at both 72 hours and 144 hours have been 
observed by our group through RT-PCR analysis (data unpublished). This points to mechanical-
stimulation exerting control of p21 protein expression at the transcription level, however, a direct 
link between H358 cell cycle changes and mechanically stimulated NF-κB transcription factor 
activation has not yet been investigated. 
There are increased levels of cyclin B1, CDK1, and p21 in mechanically stretched A549 cells 
(relative to statically culture cells) stalled in M-phase after 72 hours. This trend is reversed at the 
144-hour time point for all three proteins, with mechanically active A549 cultures showing 
decreases relative to statically cultured cells, though expression of cyclin B1, CDK1, and p21 are 
relatively consistent in mechanically active cell cultures at both time points. There are significant 
decreases in G0/G1 and S phase cells at 144 hours with forces, accompanied by small but not 
statistically significant increases in G2 and M phase cell counts. The return of M-phase cell counts 
to levels comparable to un-stretched cells at 144 hours without observed changes in relative 
levels cyclin B1, CDK1, or p21 indicate the M-phase changes are not directly linked to levels of 
these three protein regulators. Further studies will be necessary to track mechanisms behind the 
transient M-phase changes in A549 cells. The low cyclin B1 levels in both cell lines during M-
phase accumulation could indicate some form of effective cyclin B1 depletion resulting in delays 
in mitotic completion. Cyclin B1 accumulates at kinetochores during prometaphase, where it plays 
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a role in spindle formation [56] forming the proper attachments between kinetochores and 
microtubules [62]. Low levels of cyclin B1, therefore, could retard spindle formation, stalling exit 
from the M-phase. In the case of A549 cells stalled at 72 hours, this again seems unlikely as the 
sole mediator of M-phase progression. A549 cells at 144 hours no longer showed significant 
changes in M-phase cell numbers between stretched and un-stretched cells, however cyclin B1 
levels were decreased in stretched cells at 144 hours. This would indicate that cyclin B1 depletion 
alone is not responsible for M-phase changes in A549 cells. This could potentially fit with cyclin 
B1 levels and M-phase counts in H358 cells at 144 hours, though further investigation would be 
warranted. 
That changes were seen in both cancer cell lines while none were observed in the non-
tumorigenic epithelial line was intriguing. Successful cancer chemotherapeutic treatments often 
rely on shutting down cell division by attacking cancerous cells at specific phases in their cell 
cycles. Different cancers often have differing aberrations in their cell cycles that allow them to 
circumvent normal cell cycle controls in differing ways, contributing to the difficulty of developing 
new therapies. 
To address a few limitations of this study, it is important to note that asynchronous cells were 
used throughout this cell cycle investigation. The use of asynchronous cells was due to the 
relatively long time period of the experiment, but the use of both synchronized cell cultures and a 
greater number of closer time points could be used to provide additional insight into changing cell 
cycle kinetics. Serum starvation prior to the addition of a mechanical stimulus could be used to 
create an accumulation of cells at G1, then subsequent reintroduction of serum into culture media 
would produce cells that are in cell cycle synchrony prior to the addition of a tensile stretch. A 
number of other methods of synchronizing cells could be used in this context to provide further 
information about changes in cell cycle distribution. 
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Another limitation of this study is the lack of identification of either quiescent or senescent 
cell populations. Detection of and discrimination between cells that are actively dividing, quiescent 
cells that are withdrawn from the cell cycle but are still cell cycle competent, and senescent cells 
that are permanently arrested can be accomplished through various staining methods for flow 
cytometry analysis. Such discrimination between cell populations could assist in contextualizing 
cell cycle accumulation shifts seen with mechanically active culture conditions, making quiescent 
and senescent cell detection potentially worthwhile inclusions in this and other similar studies. 
In conclusion, we have found that mechanically active culture conditions cause changes in 
cell cycle phase accumulation in two lines of lung epithelial cells. The precise mechanisms behind 
the cell cycle changes still remain to be elucidated, but they appear to vary depending in part on 
the particular cell cycle abnormalities inherent in the cancer cell line in question. These results 








A very common approach to the treatment of cancer is chemotherapy. A chemical compound, 
or cocktail of multiple compounds, is delivered to the body with the intention of killing the aberrant 
cancerous cells. Particular chemotherapeutic approaches vary depending on the type of cancer 
present. One commonly used approach systemically targets all rapidly-dividing cells, cancerous 
or not, to induce cell death. Compounds used to induce the death of rapidly dividing cells 
accomplish this task using a few different approaches. Some agents work to prevent normal 
cytoskeletal behavior during mitosis, either through prevention of microtubule assembly in the 
case of vinca alkaloids, or prevention of disassembly in the case of taxanes. The functional 
assembly and disassembly of microtubules is required for successful partitioning of DNA into 
newly-forming cells during the mitotic phase of the cell cycle; when this fails apoptosis is triggered. 
Other approaches work through physical alteration of DNA structure to disrupt DNA replication 
and induce apoptosis. This can be accomplished using compounds that cross-link DNA and 
compounds that are incorporated into DNA during cell replication by mimicking nucleotides, both 
of which lead to catastrophic failure during DNA replication, thereby prompting apoptosis. One 
well known example of a compound that works through physical DNA alteration is cisplatin. 
Cisplatin was one of the first platinum containing compounds used as an antineoplastic agent for 
treatment in a variety of cancers, and is part of a standard of care regimen for many different 
types of malignancies. Cisplatin works by interfering with DNA replication by crosslinking DNA 
most frequently at guanine residues, resulting in DNA crosslinking. When DNA strand separation 
fails during the normal course of cell division due to crosslinking, DNA repair mechanisms are 
called into action that attempt to rectify the failure of separation. Nucleotide excision repair 
mechanisms can often mitigate intrastrand crosslinking, depending on the particular nature and 
location of the crosslinking, however, interstrand crosslinks are not repaired by these nucleotide 
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repair mechanisms. The inability to repair the crosslinks ultimately leads to activation of 
downstream signaling cascades involving p53, MAPK, and p73 which lead to the induction of 
apoptosis. Targeting all rapidly-dividing cells is effective at killing cancerously transformed cells, 
but also targets normal rapidly-dividing cells, leading to the oft-dreaded side effects most 
commonly associated with chemotherapy, including loss of hair, nails, immunosuppression, and 
gastrointestinal distress. 
A number of targeted therapies exist that attempt to hone in on cancerous cells by targeting 
particular molecular targets present in cancer cells. Targeted therapies specifically target gene 
products specific to cancerously transformed cells, such as the targeting of onco-fusion proteins, 
tyrosine kinase inhibition of growth factors present in mutated forms on the surface of cancer 
cells, or other gene products specific to cancerously transformed cells. For NSCLC, EGFR is a 
common target for a targeted therapeutic approach. Therapies that target EGFR work by targeting 
either EGFR’s tyrosine kinase domain or by blocking EGFR’s extracellular ligand binding domain. 
Both approaches ultimately inhibit EGFR signal transduction, thereby working to block cellular 
proliferation and survival. Tarceva (erlotinib) is one commonly used agent that targets the tyrosine 
kinase domain inhibitor (EGFR-TKI) for NSCLC treatment. Zactima (vandetanib) is another 
EGFR-TKI that additionally targets the vascular endothelial growth factor receptor (VEGFR), and 
has been under investigation for use in treating NSCLC. Targeted therapies are not without side 
effects of their own, but they can decrease damage done to normal cells in the body, helping to 
minimize side effects traditionally associated with chemotherapy. 
Regardless of the chemotherapeutic approach used, the broad goal is the same: to halt 
replication of cancer cells. Cell replication is a complex process involving the transmission of 
signals from outside the cell to the cell surface, initiating cell signaling pathways that lead to the 
interior of the nucleus and ultimately cell replication, and physical environmental cues can lead to 
changes in proliferation of cells through communication via cell-cell contacts [63-65]. With this in 
mind, and considering the changes in proliferation, EMT marker expression, and cell cycle 
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progression observed in response to cyclic stretch in the previous studies, we wanted to look at 
the impact of a mechanically active culture environment on cellular responses to 
chemotherapeutic agents in comparison to responses observed in cells cultured in a static 
environment. 
4.2 Methods 
4.2.1 Cell Culture and Mechanical Stimulation 
The two non-small cell lung cancer (NSCLC) lines used in this study, a bronchoalveolar line 
NCI-H358 (ATCC) and an alveolar adenocarcinoma line A549 (ATCC), were obtained from 
American Type Culture Collection (ATCC). H358 cells were cultured in RPMI-1640 (Sigma 
Aldrich) and A549 cells were cultured in HAM’s F12K (ATCC). Both were supplemented with 10% 
Fetal Bovine Serum (Sigma Aldrich) and 1% Penicillin Streptomycin (Sigma Aldrich). 
Both cell lines were individually cultured in six-well Bioflex Collagen I plates (Flexcell 
International) as described previously. To compensate for an anti-proliferative effect observed in 
mechanically stimulated cells in trial studies for this project, a differential seeding density was 
used for each cell line to achieve an approximately equivalent degree of confluence immediately 
prior to application of a drug treatment (three days). This was intended to minimize differing 
amounts of cell-cell interaction between mechanically active or statically cultured cells as a 
variable. H358 cells were seeded at 100,000 cells/well for static cells and 170,000 cells/well for 
the group exposed to forces. A549 cells were seeded at 20,000 cells/well for static cells and 
35,000 cells/well for cells exposed to forces. Cells were allowed to attach to the plate for 24 hours 
prior to the application of forces. After 24 hours, a FX-4000 Tension plus unit (Flexcell 
International) was used to apply a tensile force to cells, as described in Chapter 1.4. 
4.2.2 Administration of Chemotherapeutic Agents 
Three drugs were investigated for this study: cisplatin, Tarceva (erlotinib), and Zactima 
(vandetanib). One of three drugs were applied to randomized wells for the “dosed” cell groups for 
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both mechanically active and static cell culture groups at 72 hours after initial seeding of cells; 
this was 72 hours after application of tensile forces to the mechanically active cell culture groups. 
A dose corresponding to the IC90 for each drug, chosen to ensure significant inhibition of cell 
growth in statically cultured cells, was determined using serial dilutions of drug in a dose-response 
study for each cell line, conducted under standard static culture conditions in a 96-well plate. The 
calculated IC90 values for each were very similar in both cell lines, leading to use of the same drug 
concentrations for drug dosing in both cell lines for each drug. Each drug was dissolved in DMSO 
and spiked into cell culture media to produce final concentrations after addition of 1 mL to the cell 
culture wells as follows: 5 µM for Tarceva, 50 µM for cisplatin, or 50 µM for Zactima (Table 2). 
The “No Drug” groups for each cell line were given 1 mL of culture media spiked with DMSO only 
at an amount equivalent to the amount of DMSO used in the drug group. Cells were then cultured 
for an additional three days, either statically or using the Flexcell as described above 
corresponding to their original forces or no-forces designation. 
4.2.3 Cell Harvesting and Counting 
Three days (144 hours total) after administration of drug cells were harvested from each well 
individually using TrypLE (Gibco) and transferred to new labeled six-well plates in order to 
maintain treatment group identities. Briefly, media was removed from the culture wells to their 
corresponding new labeled six-well plates and 300 µL of TrypLE was added to each culture well. 
Each well’s reserved media was then used to transfer dislodged cells from the culture wells to the 
new plates. The volume of each well was measured and brought up to a total volume of 4 mL 
using phosphate-buffered saline. Cell counts were then taken using 1 mL of cells/media from 
each well using a Vi-CELL Cell Counter (Beckman Coulter) and reported as a cell count per 4 mL 
of media. 
38 
4.2.4 Data Analysis 
Viable cell counts as reported by the Vi-CELL are per 1 mL of sample. These reported cell 
counts were converted to viable cell counts per original sample well volume of 4 mL by multiplying 
each reported cell count by four. The viable cell counts for each of the three drug studies and 
each cell type were separated into a “No Forces” group not exposed to a cyclic tensile stretch, 
and a “With Forces” group that was subjected to cyclic stretch for the duration of exposure to one 
of the three drugs. Viable cell counts were compared using two-way ANOVA with a Bonferroni 
post-hoc analysis. 
In order to look at how exposure to forces impacts the effect of the drugs used in this study, 
a percent reduction in viable cell counts for both forces treatment groups was calculated for each 
cell line and drug combination. The percent reductions observed for the “No Forces” and “With 
Forces” groups were calculated as follows: the mean viable cell count for each drugged group 
was subtracted from the mean viable cell count for the corresponding un-drugged group. This 
difference was then divided by the mean viable cell count for the un-drugged group, yielding a 
percent reduction. Data was analyzed using a Student’s t-test. Significance was set at p < 0.05. 
All statistical analyses were conducted using GraphPad Prism Version 5.04 (GraphPad Software, 
Inc.). Each experiment was repeated a minimum of three separate times. 
4.3 Results 
4.3.1 Zactima Increases Cell Death in Mechanically-Stretched H358 Cells 
Significant main effects were seen for drug treatment in both A549 cells (F(1,4)=22.02, 
p=0.0094) and H358 cells (F(1,4)=13.94, p=0.0202), however, though reductions in cell counts 
were observed with tensile stretch, the main effect of tensile stretch was short of significance in 
both cell lines. An interaction effect between Zactima and mechanical cell culture was not 
observed in either cell line. See Figure 13a and Figure 13c for A549 and H358 cell counts, 
respectively. 
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Comparing the “No Forces” and “With Forces” groups for A549 treated with Zactima, there 
was perhaps a slightly greater reduction in the percent reduction in viable cell counts in the 
“Tensile Stretch” group than in the static culture group at the end of the six-day study, however 
this was not considered significant (Figure 13b). In H358 cells, a significantly greater percent 
reduction in viable cell counts in Zactima treated cells exposed to forces was seen at the end of 
treatment as compared to unstretched cells (Figure 13d). 
4.3.2 Tarceva Efficacy Slightly Increased in Mechanically Stretched Cells 
A549 (Figure 14a and b) and H358 (Figure 14c and d) cells showed statistically insignificant 
cell viability changes in the “With Forces” groups as compared to cells grown and treated under 
static culture conditions with Tarceva exposure. 
4.3.3 Cisplatin Efficacy Was Decreased in Mechanically Stretched Cells 
A549 cells showed significant main effects for the application of tensile stretch (F(1, 8)=14.58, 
p=0.0051), for drug treatment (F(1,8)=35.74, p=0.0003), and a significant interaction effect 
(F(1,8)=12.71, p=0.0073). Post hoc comparison with a Bonferroni correction indicated a change 
in viable cell counts of undrugged cells between stretched and unstretched conditions that was 
significant (t(8)=6.748, p<0.001), but drugged cells did not show a significant change with the 
application of stretch (Figure 15a). H358 cells showed similar results, with a significant main effect 
for tensile stretch (F(1,12)=12.49, p=0.0041), for cisplatin treatment (F(1,12)=18.73, p=0.0010), 
and a significant interaction effect (F(1,12)=7.247, p=0.0196). Significant changes were seen in 
undrugged viable cell counts between stretched and unstretched cultures (t(12)=4.403, 
p=0.0052), as well as a significant change between drugged and undrugged cells without a tensile 
stretch (t(12)=4.963, p=0.0020). There was no significant difference between drugged cell counts 
in stretched and unstretched cells and, interestingly, no significant effect of drug on stretched cell 
counts (Figure 15c). In both cell lines, the application of tensile stretch itself is decreasing cell 
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counts significantly, however, exposure to tensile stretch also appears to correlate with observed 
decreases in cisplatin activity. 
Cisplatin yielded decreased percent reductions in the “With Forces” groups for both cell lines, 
with A549 cells showing statistically significant increased reduction in viable cells in the “With 
Forces” group compared to the unstretched group, (t(3)=5.907, p=0.0097) (Figure 15b). Changes 
in H358 cell viability reductions between stretched and unstretched cells were not statistically 
significant, but showed a similar trend as with A549 cells (t(3)=1.802, p=0.1694) (Figure 15d). 
4.4 Discussion 
Cisplatin’s interference with DNA replication leads to the death of the fastest proliferating 
cells, making it effective against carcinogenic cells, which typically replicate at a faster rate than 
non-carcinomic cells in vivo. In this experiment, both cell lines used were carcinomic allowing for 
focus on changes seen with the application of a cyclic stretch in the culture conditions. A greater 
reduction in viable cells was seen in cells not exposed to stretched culture conditions in both A549 
and H358 cells, as compared to cells exposes to cyclic stretch. The differences in percent 
reduction in viable cells between stretched and non-stretched cells was only observed to be 
statistically significant in the A549 cell line. Considering cisplatin’s greater efficacy against more 
rapidly proliferating cells, it may be reasonably explained by the presence of a cyclic stretch 
causing a decrease in proliferation of cells as compared to non-stretched cells, and so a 
decreased efficacy against cells exposed to a cyclic stretch. The decreased proliferation observed 
in the study described in Chapter 2 is consistent with the observed decrease in cisplatin efficacy 
observed here, though the influence of tensile stretch alone on proliferation makes interpretation 
of these results more complicated. 
Zactima acts against malignantly transformed cells through kinase inhibition of a number of 
cell receptors, including the epidermal growth factor receptor (EGFR), the vascular endothelial 
growth factor receptor (VEGFR), and RET-tyrosine kinase. EGFR is a transmembrane receptor 
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tyrosine kinase that plays a central role in the regulation of cell division and cell death. Activation 
of EGFR through ligand binding on the cell surface leads to dimerization that activates the tyrosine 
kinase domain. Tyrosine kinase domain activation leads to autophosphorylation of multiple 
receptor tyrosine residues which results in the recruitment of adapter proteins that subsequently 
activate a number of intracellular signaling cascades responsible for gene transcription. This 
increased gene transcription results in increases in cancer cell proliferation, invasion and 
metastasis (through stimulation of the RAS-RAF-MAPK pathway), and decreased apoptosis 
(through activation of the PI3K/AKT pathway and the JAK/STAT pathway). Cancer cells often 
show abnormalities in EGFR signaling through mutations that lead to a hyperactive form of EGFR, 
or an overexpression of the wild-type form of the receptor. Similar to EGFR’s activity, RET-
tyrosine kinase and VEGFR activation also leads to increased proliferation and decreased cell 
death through RAS-RAF-MAPK and PI3K/AKT pathway activation. RET and VEGFR also show 
increased expression and activating mutations in cancer-transformed cells. Stopping activity of 
these cell signaling receptors through tyrosine kinase inhibitors (TKIs) have proven useful against 
a number of cancers for this reason. 
Tarceva utilizes a mechanism of action somewhat similar to that of Zactima: it acts as an 
EGFR inhibitor also through targeting of the tyrosine kinase domain. Both Tarceva and Zactima 
showed greater reductions in the percentage of viable cells present in stretched cells; this was 
the case for both cell lines. Only H358 cells treated with Zactima in the presence of a cyclic stretch 
showed a statistically significant change. Though Zactima and Tarceva are similar in their 
mechanisms of action, Tarceva showed no significant differences in efficacy between stretched 
and unstretched cells in either cell line tested. The differences in efficacy observed between 
Zactima and Tarceva in both cell lines may point to slightly different mechanisms of action 
between the two drugs. Zactima is an irreversible EGFR inhibitor, whereas Tarceva works 
reversibly against this receptor. Considering these results in the context of the EMT marker study 
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conducted in Chapter 2, it has been reported that EMT does play a role in sensitivity of NSCLC 
cell lines to EGFR inhibitors, such as Zactima and Tarceva, particularly through shifts in N-
cadherin and vimentin expression that favor a mesenchymal phenotype [66, 67]. Differences in 
Zactima and Tarceva efficacy were not significant in A549 cells in this study, so further 
conclusions relating to the application of mechanical stimulus to cell culture cannot be drawn at 
this time, though it does provide a potentially intriguing direction for further study. E-cadherin 
expression levels have also been tied to a cell’s sensitivity to EGFR-TKIs, with increased E-
cadherin corresponding with increased sensitivity to these agents [68-70]. In this regard, the 
increased E-cadherin levels observed in mechanically active H358 cultures in Chapter 2 are 
consistent with the increased sensitivity of H358 cells to Zactima observed in this drug study. The 
differences observed between Zactima and Tarceva may be resolved with further study, though 
it should be noted that AstraZeneca withdrew its new drug application for Zactima as a treatment 
for NSCLC in late 2009 due to lack of significant improvement in patients with NSCLC. 
Looking back at the cell-cycle study conducted in Chapter 3, it is interesting to note the 
correlation between cell behavior in this cell cycle study and efficacy of drugs related to the 
application of mechanical stimulation. Cisplatin resistant NSCLC cells have been shown to 
accumulate in G0/G1 of the cell cycle [71]. This is consistent with the results observed here: both 
cancer cell lines here showed increases in G0/G1-stage fractions at 72 hours (statistically 
significant in H358 cells), the time point at which both cell lines were dosed with drug, and both 
cell lines showed decreased sensitivity to cisplatin (statistically significant in A549 cells). 
One potentially important limitation of this study is the presence of activating KRAS mutations 
in both cell lines used. Both H358 and A549 cell lines have been reported to carry activating KRAS 
point mutations in codon 12, a heterozygous c.34G>T/p.Gly12Cys mutation in H358 cells and a 
homozygous c.34G>A/p.Gly12Ser mutation in A549 cells [72]. Both these mutations have the 
effect of rendering KRAS constitutively active, allowing KRAS signaling to occur with or without 
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upstream activation of EGFR, leading to cell-cycle progression in the absence of EGFR activation. 
As both Tarceva and Zactima work by inhibiting EGFR signaling, their usefulness against tumors 
harboring KRAS mutations can be limited. The presence of KRAS activating mutations can be a 
strong predictor of response to EGFR-TKI therapies such as Tarceva and Zactima [73], though 
the ability to predict response based on KRAS mutation status may depending on the type of 
tumor. Molecular subtyping of KRAS, among other genes, is routine in the treatment of colon 
cancer [74], however, the role of KRAS mutation status in predicting response to EGFR-TKIs is 
less definitive in NSCLC [75, 76]. It is not entirely surprising that A549 cells, carrying a 
homozygous activating KRAS mutation, may not respond well to Zactima in either treatment 
group, and showed no significant difference between the stretched and static cell cultures. H358 
cells, carrying a heterozygous KRAS activating mutation, responded better as compared to A549 
cells, and showed increased efficacy in mechanically stretched cells. The presence of a 
heterozygous KRAS mutation in H358 cells, leading to production of some normal (non-
constitutively active) KRAS protein in addition to the altered form, may have contributed to its 
better response when compared to the response in A549 cells, but the impact of an activating 
KRAS mutation cannot definitively explain the response at this time. Despite the lack of definitive 
link between the presence of an activating KRAS mutation and response to EGFR-TKIs in 
NSCLC, utilizing cell lines that do not harbor mutations in proteins involved in EGFR signaling, in 
addition to including a non-tumorigenic cell line, such as the NL-20 line used in the cell cycle study 
described in Chapter 3, would be beneficial in studies of the response of stretched cells to drugs, 
particularly drugs such as the EGFR-TKIs described here. 
There are a few ways that the drug dosing approach itself may be improved in this study, 
and these could serve as potential starting points for future exploration of this topic. The IC90 
value, as determined by a dose-response study in both tumorigenic cells lines 96-well plates as 
described above, was used as the drug dosing concentration for each cell line. This high dose 
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was chosen to significantly inhibit cell growth in non-stretched cells, however, taking each drug 
dose down to its IC50 value may provide a better view of growth inhibition changes with applied 
stretch. Another potentially interesting approach to investigating changes in response to 
chemotherapeutic agents in the presence of mechanical stimulation could involve conducting a 
dose-response study for each drug in mechanically active cultures versus static cultures to create 
comparative IC50 values. 
In conclusion, we demonstrated that in vitro exposure of cells to mechanical stimulation can 
result in altered cellular responses to drug, though explanations for these altered responses still 
remain to be understood. The differences in biochemical profiles and signaling pathway 
alterations between these cells lines themselves may contribute to differing responses to the 
same drug, which underscores some of the continued general difficulties in developing new 
treatments for cancer. As our understanding of cellular mechanics and mechanotransduction 
continues to increase, the incorporation of physiologically representative forces to cell culture can 
allow research and development paradigms for the discovery of new cancer drugs to evolve. 
Along with development of high-throughput approaches for mechanically active cell culture 




Chapter 5: Conclusions and Future Directions 
 
5.1 Conclusions 
In this study we used a dynamic cell culture system to create mechanically active 
environmental conditions with the hypothesis that tensile (mechanical) forces in lung cancer cells 
play an important role in determining cellular response to chemotherapeutic agents. In particular, 
we wanted to compare cells cultured with exposure to a tensile force, and compare those cells to 
cells cultured under static in vitro culture conditions classically used in biological studies. 
The first study investigated proliferation changes and changes in expression levels of 
selected EMT-associated proteins in A549 and H358 cell lines in response to a tensile stretch. 
Both cell lines showed decreased proliferation with exposure to a tensile stretch over the duration 
of the study. Observation of the morphological changes showed that H358 cells tended to detach 
from the wells and form spheroid-like aggregates in the mechanically active culture environment. 
Shifts in expression levels of selected EMT-associated markers were somewhat consistent with 
the morphological changes seen, particularly in H358 cells. Further, EMT marker levels in both 
cell lines hinted toward the epithelial-like H358 cell line showing less signs of EMT, and the more 
mesenchymal A549 cell line showing more signs of undergoing EMT and a more invasive 
phenotype. As EMT is a hallmark in metastasis formation, and as EMT has been shown to play a 
critical role in resistance of cancer to chemotherapies [73], this study serves as an interesting 
starting point for further investigation of the role of mechanotransduction in the response of cancer 
cells to drugs and in cancer drug discovery. 
The second study looked at changes in cell cycle progression in A549 and H358 cells, as 
well as a non-tumorigenic cell line NL-20, under mechanically active culture conditions at both a 
72-hour time point and a 144-hour time point. In mechanically active culture at the 72-hour time 
point, H358 cells showed an increase in G0/G1 phase cells and a decrease in G2 phase cells, 
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and this corresponded with increased CDK1, cyclin B1, and p21 expression observed at this time 
point. A549 cells showed similar increased in CDK1, cyclin B1, and p21 expression in 
mechanically active cell cultures at the 72-hour time point, but showed an increase only in the 
number of cells in M-phase; the number of cells in G0/G1, S, and G2 were comparable in both 
active and static cell cultures. H358 cells at the 120-hour time point showed a decrease in S-
phase cells and an increase in M-phase cells in mechanically active cultures, corresponding with 
the observation of increased p21 levels in these cells. The A549 cell line showed decreases in 
both G0/G1 and S phase cells at 144 hours in mechanically active cultures. This was coupled 
with observed decreases in cellular levels of p21, cyclin B1, and CDK1 at this time point. 
The third study compared cellular responses of two different cell lines to three different 
chemotherapy drugs in with or without exposure to mechanically active culture conditions. For 
cells exposed to cisplatin, the A549 cell line showed decreased efficacy in cells cultured in a 
mechanically active environment. For Zactima-treated cells, the H358 cell line showed increased 
reduction in viable cells in the mechanically active growth environment. 
Taken together, we showed a decreased efficacy of cisplatin in cells grown with tensile 
stretch, corresponding with observed increases in G0/G1 cell cycle fractions at the time of drug 
dosing (72 hours) due to stretch alone. We also showed an increased efficacy of EGFR-TKIs in 
the bronchoalveolar H358 cell line, which corresponded with increased E-cadherin expression in 
stretched cells; the changed efficacy of EGFR-TKIs observed appeared to be influenced, in part, 
by EMT marker expression alterations in stretched cells. The presence of a strong anti-
proliferative effect in both cell lines with tensile stretch alone as well as the presence of activating 
KRAS mutations complicates interpretation of the drug study results, however future study could 
assist in disentangling the response to stretch from the response to drug. 
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5.2 Future Directions 
As our understanding of the pathways involved in and influenced by mechanotransduction 
increases, the incorporation of physiologically relevant mechanical stimulation in cellular research 
paradigms will almost certainly become not only necessary but also routine. The incorporation of 
mechanotransduction in cell culture has important implications for both our understanding of 
cellular processes in our bodies and for the development of new treatments for when these cellular 
processes go awry. Though interest in studies involving the impact of mechanically active cell 
culture on cellular behavior has increased over the past several years, this field is still relatively 
new and many opportunities for discovery still remain. Numerous directions for future work in 
mechanotransduction and cell culture are available in the context of the studies described in this 
thesis; a few possibilities are described below. 
5.2.1 High Throughput Cell Culture Format 
In this study, the bioreactor used was a commercially available model from Flexcell 
International Corporation that was available in a six-well format. The adoption of a cell culture 
model such as the one used in this study would require development of a high-throughput format 
for such a model to be of practical use in a typical laboratory setting, but particularly for use in any 
drug discovery applications, the potential for which this study was intended to investigate. For 
practical reasons, the process of drug discovery and development requires a culture format that 
allows for the screening of numerous drug candidates simultaneously to detect leads for 
subsequent study. It is simply not feasible for the purposes of screening numerous drug 
candidates to rely on a six-well cell culture format, and other studies of biological effects of 
mechanically active culture conditions, such as those in the studies presented here, would benefit 
tremendously from the availability of a greater number of sample wells. Flexcell International has 
developed a version of the culture plates used in this study that are scaled down to a 24-well 
format, but such plates still represent a prohibitively low-throughput format for routine use in 
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research and development applications. A variety of new bioreactors have been developed and 
investigated to bring a higher-throughput format [77], which will certainly continue to bring the 
study of the mechanics of cellular life into greater prevalence. 
5.2.2 Proteomics 
During the course of this study western blotting was used to probe for relative changes in 
abundance of a very small number of proteins related to cell cycle progress. Looking at cellular 
protein abundance changes on a total cell scale has the potential to point to differences in protein 
abundance that otherwise may not have immediately followed from the results presented in the 
studies that serve as the focus of this paper. 
Proteomic studies have been used as a broad-scale approach to the identification of proteins 
of interest in mechanically active cultures of varying types, including human optic nerve head 
astrocytes [78] and rat proximal tubule cells [79], to list a very few. Frequently, whole cell lysates 
are created and separated first by isoelectric focusing (IEF), in which proteins are separated on 
a gradient pH strip by differences in their isoelectric points. Strips containing IEF-focused proteins 
are then separated by weight using SDS-PAGE electrophoresis. The result is a gel that represents 
a grid of proteins for the separated sample, and protein grids can then be compared 
computationally to detect differences in protein expression for subsequent downstream mass-
spectrometric identification. Such a broad-scale approach would be potentially interesting to 
probe for differences in cellular proteomes of cells cultured under the mechanically active 
conditions studied here. 
5.2.3 Incorporation of Representative Extracellular Environment 
The cell culture conditions under investigation in this study involved the addition of equibiaxial 
strain to cells growing in monolayers in culture wells. Culturing cells in monolayers in vitro has 
been and will continue to be an important approach for biological studies, however, cells cultured 
in monolayers in traditional culture plates are not exposed to the variety of mechanical and 
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chemical signals experienced when cultured in more complex three-dimensional structures. Cells 
in the body reside in a complex three-dimensional network of extracellular matrix proteins, 
polysaccharides and proteoglycans, as well as other types of cells, that all serve to provide 
structural and chemical support to the groups of cells comprising various tissues. The 
incorporation of a more representative cellular environment, one that more closely represents the 
in vivo environment through incorporation of co-culture models, three dimensional culture 
environments, and inclusion of a more representative combination of extracellular matrix 
components could go far toward understanding the impact of mechanotransduction in the context 
of a cell’s multifaceted in vivo environment. 
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Figure 1: General schematic depicting some examples of cellular mechanotransduction. Mechanical 
stimuli external to the cell activate cell-surface mechanical sensors in the plasma membrane which convert 
physical stimuli into biochemical signals. These signals result in the activation of various cellular signaling 
pathways, leading to the regulation of gene expression and, ultimately, the modulation of cellular function. 





Figure 2: Flexcell base station and Bioflex plate. The base station holds four flexible-well plates that are 
distensible from below via connection to vacuum pressure through the tubing shown on the left of the base 
station (a). Vacuum pressure pulls the flexible wells of the Bioflex plate down over a loading post, delivering 




Figure 3: H358 bronchoalveolar epithelial cells show a halt in proliferation with mechanical cell 
culture conditions. Each time point indicates the time elapsed from initiation of the experiment. Cells were 
allowed to grow statically in both groups for 24 hours; the application of a tensile stretch to the “With Forces” 
group occurred immediately following cell counts for the 24-hour period. The potential impact of applied 
tensile stretch is present starting at the 48-hour time point and beyond. Significant differences in viable cell 
counts between actively at statically cultured cells at each time point appeared at 48 hours (t(3)=15.06, 
p=0.0006), and continued at 72 hours (t(2)=5.912, p=0.0274), at 96 hours (t(2)=8.621, p=0.0132), at 120 
hours (t(2)=7.898, p=0.0157), and at 144 hours (t(2)=15.83, p=0.0040). Unpaired Welch’s t-test was used 




Figure 4: H358 bronchoalveolar cells formed detached spheroidal aggregates with mechanically 
active cell culture conditions. Cells cultured without mechanical stimulation remained adherent to the 
surface of the wells at 72 hours (a), whereas detachment and clustering of cells is present in cells cultures 
with mechanical stimulation (b). This is continued at the 144-hour time point, with cells cultured without 
stimulation remaining adherent (c), and cells cultured with stimulation continuing to show detachment and 









Figure 5: A549 alveolar epithelial viable cell counts exhibit a proliferative halt with mechanical 
forces. Each time point indicates the time elapsed from initiation of the experiment. Cells were allowed to 
grow statically in both groups for 24 hours; the application of a tensile stretch to the “With Forces” group 
occurred immediately following cell counts for the 24-hour period. The potential impact of applied tensile 
stretch is present starting at the 48-hour time point and beyond. Significant differences in viable cell counts 
between actively at statically cultured cells at each time point appeared at 72 hours (t(3)=46.79, p<0.0001), 
at 96 hours (t(2)=20.98, p=0.0023), at 120 hours (t(2)=46.30, p=0.0005), and at 144 hours (t(2)=24.36, 
p=0.0017). Unpaired Welch’s t-test was used for comparison of viable cell counts at each time point. Data 






Figure 6: A549 cells remained adherent and morphologically unchanged for the duration of the 
experiment, with or without exposure to mechanically active culture conditions. At 72 hours, both 
the statically cultured group (a) and the mechanically active cultured group (b) remained adherent. This is 
continued at the 144-hour time point for statically cultured cells (c) and the mechanically active group (d). 






Figure 7: Expression of the epithelial marker E-cadherin is increased in H358 bronchoalveolar 
epithelial cells at 144 hours of culture with forces. Comparison of relative epithelial marker levels 
between static and active culture in H358 (a) and A549 (b) cells. H358 cells showed increased E-cadherin 
at 144 hours with forces (a). Relative expression of β-catenin was slightly lower in A549 cells at the 144-
hour time point (b). All other markers were relatively unchanged.  
 
 
Figure 8: Mesenchymal markers are decreased in H358 bronchoalveolar cells and increased in A549 
alveolar cells. H358 cells showed decreased Vimentin expression at 72 hours, and decreased Fibronectin 
levels at 144 hours (a). A549 showed increases in Vimentin at 144 hours and N-cadherin at both time points 







Figure 9: Generalized depiction of cell cycle proteins and checkpoints investigated. The progression 
of cells through the distinct phases of the cell cycle is monitored through activity of cell cycle associated 
proteins. Cyclin B1-cdk1 complexes play a role in successful G2/M transition. P21 plays an inhibitory role 
both through blockade of cyclin B1-cdk1 activity at the G2/M transition point as well as through inhibition of 
G1/S transition. Cell cycle checkpoint proteins investigated in this study are marked in red. Adapted from 





Figure 10: Bronchoalveolar epithelial H358 cells show increased G0/G1 cell fractions at 72 hours, 
with a shift to increased mitotic-phase cells at 144 hours. After 72 hours, the percentage of cells in 
G0/G1 was increased in cells culture with exposure to a cyclic stretch (t(8)=4.186, p=0.0031) and the 
percentage of G2 cells was decreased in the mechanically active culture environment (t(8)=4.437, 
p=0.0022) relative to static culture (panel a). This corresponded with increased levels of Cyclin B1 at 72 
hours in the active culture environment (panel c). At 144 hours decreased S-phase (t(4)=5.358, p=0.0059) 
and increased M-phase (t(4)=10.68, p=0.0004) cell fractions were observed in cells grown with tensile 
stretch (panel b), corresponding with increased p21 (panel d). Unpaired Student’s t-test was used for 






Figure 11: Shorter-term exposure to mechanically active culture yields slight but significant 
increases in mitotic A549 alveolar epithelial cells. Distribution of A549 cells in cell cycle phases and 
protein expression after 72 hours of culture (a and c, respectively) or 144 hours of culture (b and d, 
respectively). The percentage of cells in M-phase after 72 hours of culture was increased in cells cultured 
with cyclic stretch (t(4)=2.950, p=0.0420) (panel a), corresponding to increased Cyclin B1, CDK1, and p21 
(panel c). After 144 hours, cells culture with cyclic stretch showed decreases in both G0/G1 (t(4)=2.962, 
p=0.0415) and S-phase (t(4)=4.273, p=0.0129) distributions (panel b), accompanying decreased relative 
amounts of Cyclin B1, CDK1, and p21 (panel d). Unpaired Student’s t-test was used for comparison 
between statically cultured cells cultured with tensile stretch of cell cycle distribution for each phase. 
Unpaired Student’s t-test was used for comparison of cell cycle distribution at each cell cycle stage. Data 








Figure 12: Non-tumorigenic lung NL-20 epithelial cells show no differences in cell cycle distribution 
with forces. Distribution of NL-20 cells in cell cycle phases after 72 hours of culture (a) or 144 hours of 
culture (b). No significant differences were seen between cells cultured statically versus cells cultured with 
cyclic stretch at either time point. Unpaired Student’s t-test was used for comparison of cell cycle distribution 




Figure 13: Zactima shows increased efficacy against H358 bronchoalveolar epithelial cells when 
applied to mechanically active culture. Viable cell counts for A549 alveolar cells (a) and H358 
bronchoalveolar cells (c) show decreases in viable cell counts with the application of a cyclic stretch to cell 
culture. The percent reduction increased in both cell lines (b and d), but was only significant in H358 cells 
(d) (t(2)=5.030, p=0.0373). Viable cell counts were compared using two-way ANOVA with Bonferroni post 
hoc multiple comparisons. Unpaired Student’s t-test was used for percent reduction comparisons. Data is 







Figure 14: Mechanically active culture had no significant effect on Tarceva efficacy. Viable cell counts 
in A549 (a) and H358 (c) cells. The percent reduction was slightly but statistically insignificantly higher in 
both cell lines when cultured in mechanically active wells (b and d). Viable cell counts were compared using 
two-way ANOVA with Bonferroni post hoc multiple comparisons. Unpaired Student’s t-test was used for 
percent reduction comparisons. Data is shown as mean ± SD. 
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Figure 15: Cisplatin shows decreased efficacy against A549 alveolar epithelial cells when applied 
to mechanically active culture. Viable cell counts for A549 alveolar cells and H358 bronchoalveolar cells 
show decreases in viable cell counts with the co-application of a cyclic tensile stretch and 50 µM cisplatin 
to cell culture (panels a and c, respectively). Viable cell counts were not significantly different in between 
cells cultured statically and cells cultured with tensile stretch in drugged cells, but that undrugged cells did 
show significant differences between stretched and unstretched cells (t(8)=6.748, p<0.001) (a). The percent 
reduction decreased in both cell lines (b and d), but was only significant in A549 cells (b) (t(3)=5.907, 
p=0.0097). Viable cell counts were compared using two-way ANOVA with Bonferroni post hoc multiple 
comparisons. Unpaired Student’s t-test was used for percent reduction comparisons. Data is shown as 






Table 1: Distribution of cells in each cell cycle phase. The percent fraction of cells in each phase is 
represented as the mean ± SD. 
  72 hours, Static Culture 







 N=5 N=3 
G0/G1 45.900 ± 2.743 55.440 ± 4.295 64.900 ± 1.054 65.500 ± 2.893 
S 19.700 ± 2.207 16.880 ± 2.036 12.800 ± 0.400 6.533 ± 1.986 
G2 30.960 ± 2.313 24.160 ± 2.529 21.767 ± 1.168 21.233 ± 1.060 
M 2.860 ± 1.701 3.280 ± 0.661 1.467 ± 0.208 5.767 ± 0.666 
A549 
 N=3 N=3 
G0/G1 64.480 ± 5.631 67.150 ± 3.627 66.767 ± 1.976 61.767 ± 2.155 
S 14.993 ± 6.256 14.367 ± 2.614 13.267 ± 0.777 8.733 ± 1.665 
G2 18.977 ± 1.401 16.417 ± 1.604 17.467 ± 1.528 22.867 ± 4.409 
M 1.333 ± 0.186 1.930 ± 0.297 2.267 ± 0.379 5.700 ± 4.440 
NL20 
 N=3 N=5 
G0/G1 45.833 ± 10.483 53.467 ± 3.9810 45.520 ± 4.956 46.160 ± 13.306 
S 13.033 ± 3.027 13.233 ± 3.722 16.780 ± 4.117 17.760 ± 4.605 
G2 39.600 ± 13.438 30.100 ± 1.510 36.100 ± 6.026 34.060 ± 16.612 
M 0.933 ± 0.839 2.700 ± 0.917 0.700 ± 1.192 1.440 ± 1.979 
 
Table 2: List of drugs used in this study, their mechanism of action, and their tested concentration. 
Drug Mechanism of Action Tested Concentration (IC90) 
Zactima (vandetanib) Irreversible tyrosine kinase inhibitor (VEGFR and EGFR) 50 µM 
Tarceva (erlotinib) Reversible tyrosine kinase inhibitor (EGFR) 5 µM 
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